Nisa Investment Advisors LLC Sells 4,837 Shares of Cigna Group $CI

Nisa Investment Advisors LLC lowered its stake in shares of Cigna Group (NYSE:CI) by 4.8% in the third quarter, Holdings Channel reports. The firm owned 96,704 shares of the health services provider’s stock after selling 4,837 shares during the period. Nisa Investment Advisors LLC’s holdings in Cigna Group were worth $26,287,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. raised its position in shares of Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC bought a new stake in shares of Cigna Group during the 2nd quarter worth $1,628,918,000. Bank of America Corp DE boosted its holdings in shares of Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after buying an additional 256,677 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after buying an additional 236,340 shares during the period. Finally, Legal & General Group Plc acquired a new position in Cigna Group in the 2nd quarter valued at $542,779,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 22,730 shares of company stock worth $6,293,359. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Guggenheim lifted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, September 26th. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Finally, Evercore assumed coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $338.24.

Cigna Group Trading Down 0.6%

Shares of Cigna Group stock opened at $304.74 on Thursday. The firm has a market capitalization of $80.53 billion, a PE ratio of 12.61, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company’s fifty day moving average price is $280.49 and its two-hundred day moving average price is $282.73. Cigna Group has a 52-week low of $239.51 and a 52-week high of $311.34.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts expect that Cigna Group will post 30.50 EPS for the current year.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.